NH MPJE key terms

The state regulatory body that licenses pharmacists, technicians, and pharmacies in New Hampshire, adopts administrative rules, investigates complaints, and imposes discipline for violations of the Pharmacy Practice Act.

New Hampshire statutes governing pharmacy practice, including licensure, prescription handling, controlled substances, inspections, and enforcement authority delegated to the Board of Pharmacy.

The credential issued by the Board permitting a person to practice pharmacy in New Hampshire after meeting education, examination, and internship requirements and completing the application process.

A Board-issued registration allowing a pharmacy student or graduate to practice under pharmacist supervision while accumulating the practical experience required for licensure.

The credential required for support personnel who assist pharmacists with dispensing and related tasks; the Board sets qualifications, training expectations, and supervision requirements for registered technicians.

The license issued to a physical pharmacy location authorizing it to dispense drugs; it requires a pharmacist-in-charge, adequate space and security, and compliance with Board inspection standards.

Authorization for a pharmacy located outside New Hampshire to ship prescription drugs to patients in the state, subject to Board registration and compliance with New Hampshire dispensing standards.

The process by which a pharmacist licensed in another jurisdiction obtains New Hampshire licensure through score transfer or licensure verification rather than re-examination, subject to Board requirements.

The pharmacist designated as responsible for a pharmacy's day-to-day compliance with drug laws, recordkeeping, security, and personnel supervision; the Board must be notified when this role changes.

The degree of oversight a pharmacist must exercise over interns and technicians, ranging from direct observation to general availability depending on the task and the patient risk involved.

The elements a lawful prescription must contain, such as prescriber identity and signature, patient identification, drug name, strength, quantity, directions, and date, plus any state-specific content rules.

A prescription transmitted digitally from a prescriber to a pharmacy in a format the Board recognizes as valid; controlled substance e-prescriptions must also satisfy federal electronic prescribing rules.

The prescriber's permission recorded on or added to a prescription allowing repeated dispensing; the number of refills and their expiration are limited by state and federal law.

The process of moving prescription information between pharmacies so a patient can continue therapy elsewhere, with requirements for direct communication, documentation, and limits on controlled substance transfers.

The required information affixed to a dispensed container, including pharmacy and patient identifiers, drug name and strength, directions, quantity, prescriber, date, and cautionary statements.

The pharmacist's discussion with the patient or caregiver about proper use, storage, side effects, interactions, and precautions for a dispensed medication, offered at the point of dispensing.

The federal classification of drugs from Schedule I through V based on medical use and abuse potential; New Hampshire law generally mirrors these schedules and adds state-specific controls.

A prescription for a highly restricted drug that cannot be refilled and must meet stricter requirements for written or electronic issuance, emergency dispensing, and recordkeeping.

The state registration practitioners and facilities need to handle controlled substances in New Hampshire, separate from federal DEA registration and administered by state authorities.

The federal registration that authorizes a practitioner or pharmacy to manufacture, distribute, dispense, or conduct research with controlled substances under the Controlled Substances Act.

The documentation pharmacies must maintain for controlled substance receipts, dispensing, and disposal, including invoices, prescriptions, and inventories retained for the required federal and state periods.

The complete count of controlled substances a registrant must conduct every two years, documenting the date, time, and whether the count was taken from actual stock or records.

An ongoing running record of controlled substance receipts and disbursements used to reconcile expected stock with actual counts and to detect diversion or recordkeeping discrepancies.

The obligation to notify DEA and the state when controlled substances are discovered missing or lost, using the required federal form and meeting notification deadlines.

Physical and procedural safeguards such as locked storage, limited access, alarm systems, and key control that prevent unauthorized entry and protect controlled substances from diversion.

The period for which a pharmacy must keep prescriptions, inventories, invoices, and other records available for inspection, as set by state and federal requirements.

A mechanical or electronic device that stores and dispenses medications, subject to Board requirements for pharmacist oversight, accuracy checks, and documentation of use.

Requirements for preparing sterile products, including cleanroom design, environmental monitoring, personnel training, and beyond-use dating intended to prevent contamination and infection.

Requirements for preparing nonsterile preparations, covering facility space, equipment, ingredient quality, master formulation records, and finished preparation testing and labeling.

The Board's examination of a pharmacy's premises, records, and practices to verify compliance with licensing, security, and dispensing requirements, often conducted on a scheduled or complaint-driven basis.

Any preventable event that may cause or lead to inappropriate medication use or patient harm, including prescribing, dispensing, administration, and monitoring failures.

A structured, ongoing process of collecting data on errors and near misses, identifying causes, implementing changes, and measuring results to improve pharmacy safety.

A mechanism for documenting medication errors and near misses internally and, where required, to external programs, while protecting information used for quality improvement.

The process of notifying manufacturers or federal and state programs about serious adverse drug experiences, product defects, or other safety problems observed in practice.

The specific conduct for which the Board may reprimand, suspend, revoke, or restrict a license, such as fraud, incompetence, drug diversion, unprofessional conduct, or practicing while impaired.

Behavior falling below accepted standards of pharmacy practice or professional ethics, including dishonesty, confidentiality breaches, and failure to maintain required records.

Practicing pharmacy while affected by substance use, mental health conditions, or other impairments that compromise judgment or safety, often addressed through diversion or monitoring programs.

The procedural protections owed to a licensee facing discipline, including notice of charges, an opportunity to be heard, and a decision supported by evidence.

The activities a pharmacist is legally authorized to perform, such as dispensing, counseling, immunizing, and providing collaborative drug therapy management within defined limits.

A written arrangement between a pharmacist and prescriber authorizing the pharmacist to manage drug therapy for specified patients under defined protocols and communication requirements.

The legal permission for pharmacists to administer vaccines to specified age groups and populations, subject to training, certification, and any required reporting or notification.

Temporary authority granted during declared emergencies that may expand pharmacists' ability to dispense, substitute, or administer medications to protect public health.

A statewide database that collects controlled substance dispensing data so prescribers and pharmacists can review a patient's history and identify potential misuse or duplication.